These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
457 related items for PubMed ID: 950366
1. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome. Judd HL, Rigg LA, Anderson DC, Yen SS. J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366 [Abstract] [Full Text] [Related]
2. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease. de Ziegler D, Steingold K, Cedars M, Lu JK, Meldrum DR, Judd HL, Chang RJ. J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501 [Abstract] [Full Text] [Related]
3. Dynamics of plasma gonadotropin and sex steroid release in polycystic ovarian disease after pituitary-ovarian inhibition with an analog of gonadotropin-releasing hormone. Calogero AE, Macchi M, Montanini V, Mongioi A, Maugeri G, Vicari E, Coniglione F, Sipione C, D'Agata R. J Clin Endocrinol Metab; 1987 May; 64(5):980-5. PubMed ID: 3104389 [Abstract] [Full Text] [Related]
4. The impact of obesity and chronic hyperinsulinemia on gonadotropin release and gonadal steroid secretion in the polycystic ovary syndrome. Dunaif A, Mandeli J, Fluhr H, Dobrjansky A. J Clin Endocrinol Metab; 1988 Jan; 66(1):131-9. PubMed ID: 2961783 [Abstract] [Full Text] [Related]
6. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome. Rebar R, Judd HL, Yen SS, Rakoff J, Vandenberg G, Naftolin F. J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505 [Abstract] [Full Text] [Related]
7. Hormone levels following wedge resection in polycystic ovary syndrome. Mahesh VB, Toledo SP, Mattar E. Obstet Gynecol; 1978 Jan; 51(1 Suppl):64s-69s. PubMed ID: 144874 [Abstract] [Full Text] [Related]
8. The effect of ovarian wedge resection and incision on circulating gonadotropin in patients with polycystic ovarian disease. Tanaka T, Fujimoto S, Kutsuzawa T. Int J Fertil; 1978 Jan; 23(2):93-9. PubMed ID: 30730 [Abstract] [Full Text] [Related]
9. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease. Christman GM, Randolph JF, Kelch RP, Marshall JC. J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845 [Abstract] [Full Text] [Related]
10. Disruption of the synchronous secretion of leptin, LH, and ovarian androgens in nonobese adolescents with the polycystic ovarian syndrome. Veldhuis JD, Pincus SM, Garcia-Rudaz MC, Ropelato MG, Escobar ME, Barontini M. J Clin Endocrinol Metab; 2001 Aug; 86(8):3772-8. PubMed ID: 11502810 [Abstract] [Full Text] [Related]
11. Enhanced disparity of gonadotropin secretion by estrone in women with polycystic ovarian disease. Chang RJ, Mandel FP, Lu JK, Judd HL. J Clin Endocrinol Metab; 1982 Mar; 54(3):490-4. PubMed ID: 6799536 [Abstract] [Full Text] [Related]
12. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. I: Plasma luteinizing hormone, follicle stimulating hormone, testosterone, estradiol, and inhibin concentrations. Wallace EM, Gow SM, Wu FC. J Clin Endocrinol Metab; 1993 Jul; 77(1):290-3. PubMed ID: 8325955 [Abstract] [Full Text] [Related]
13. Elevations in unbound serum estradiol as a possible mechanism for inappropriate gonadotropin secretion in women with PCO. Lobo RA, Granger L, Goebelsmann U, Mishell DR. J Clin Endocrinol Metab; 1981 Jan; 52(1):156-8. PubMed ID: 6778890 [Abstract] [Full Text] [Related]
14. Effect of gonadotrophin-releasing hormone analogue (GnRH-A) administration on serum gonadotrophin and steroid levels in patients with polycystic ovarian disease. Mongioi A, Maugeri G, Macchi M, Calogero A, Vicari E, Coniglione F, Aliffi A, Sipione C, D'Agata R. Acta Endocrinol (Copenh); 1986 Feb; 111(2):228-34. PubMed ID: 3082098 [Abstract] [Full Text] [Related]
15. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C. J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511 [Abstract] [Full Text] [Related]
17. Circulating gonadotropins, estrogens, and androgens in polycystic ovarian disease. DeVane GW, Czekala NM, Judd HL, Yen SS. Am J Obstet Gynecol; 1975 Feb 15; 121(4):496-500. PubMed ID: 125040 [Abstract] [Full Text] [Related]
18. The effect of bromocriptine on gonadotropin and steroid secretion in polycystic ovarian disease. Steingold KA, Lobo RA, Judd HL, Lu JK, Chang RJ. J Clin Endocrinol Metab; 1986 May 15; 62(5):1048-51. PubMed ID: 2937800 [Abstract] [Full Text] [Related]
19. Plasma hormones in human gonadotropin induced ovulation. Wu CH. Obstet Gynecol; 1977 Mar 15; 49(3):308-13. PubMed ID: 840459 [Abstract] [Full Text] [Related]
20. Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong FH, Dahl KD. J Clin Endocrinol Metab; 1991 Oct 15; 73(4):811-7. PubMed ID: 1909705 [Abstract] [Full Text] [Related] Page: [Next] [New Search]